About Subhasree Kar
Subhasree’s keen interest in financial instruments led her to pursue a career as an investment analyst. After earning a Master’s degree in Economics, she gained knowledge of equity research and portfolio management at Finlatics.
She uses her knowledge as a fundamental analyst to help investors make informed decisions in regards to their investment portfolios.
Recent Articles By Subhasree Kar
3 Telecom Stocks With Bullish Sentiment
The telecom industry is growing with the growing demand for digitalization, rapid 5G investments, and the evolution of Gen-AI. Hence, it could be wise to invest in solid telecom stocks Turkcell Iletisim (TKC), Magyar Telekom (MYTAY), and Ooma (OOMA) now. Continue reading...
Is Uber (UBER) Poised for a Profitable Ride?
Uber (UBER) has witnessed robust growth in the last reported quarter amid a double-digit rise in revenue and bookings. However, will the company be able to maintain its performance? Keep reading...
Copart (CPRT) Earnings: Analyzing Buy Opportunities
Leading vehicle auction company Copart (CPRT) has an impressive record of surpassing analysts’ quarterly revenue and EPS estimates. Will the company be able to maintain its performance in the upcoming report? Let’s discuss some of its financials to gauge its prospects...
Deere & Co. (DE) Earnings Spotlight: Buy or Hold?
Agriculture titan Deere & Company (DE) is engaging in promising collaborations that should foster long-term growth. However, with analysts’ not-so-optimistic forecasts for the last quarter, is it worth buying DE ahead of its earnings release this week? Let’s discuss...
SHOP Earnings: Buy or Watch for Smart Moves?
Canadian e-commerce company Shopify (SHOP) delivered robust growth in the last reported quarter and gave upbeat guidance for the quarter ended December 2023. With the company scheduled to release earnings tomorrow, is SHOP a smart choice today? Keep reading...
PYPL Earnings Watch: Strategies for Smart Investors
PayPal (PYPL) has seen a significant plunge in its share price over the past year amid slowing spending and growing competition. However, is the stock worth buying today ahead of its earnings release? Let’s discuss this in detail...
Eli Lilly & Co. (LLY) Pre-Earnings Moves: Buy or Watch?
Eli Lilly (LLY) saw steady growth in its last reported quarter, driven by sales from its popular diabetes drug Mounjaro. The stock has had an impressive run over the past year. However, will the momentum be sustained following its upcoming earnings release scheduled for tomorrow? Read on...
AbbVie (ABBV) Earnings Preview: Buy or Sell Opportunities
While AbbVie (ABBV) saw a decrease in net revenues and EPS in the last reported quarter, it raised its 2023 adjusted EPS guidance range. With the company gearing up to report fourth-quarter 2023 results tomorrow, is the stock worth buying today? Keep reading...
Merck (MRK): Quarterly Earnings - What Investors Should Know
Pharma giant Merck (MRK) has an impressive record of surpassing analysts’ expectations in its top and bottom lines. So, is the company on track to top estimates in the upcoming earnings release? Let’s discuss some of its financials to gauge its prospects...